Results 161 to 170 of about 36,079 (213)

Promoter-level expression clustering identifies time development of transcriptional regulatory cascades initiated by ErbB receptors in breast cancer cells. [PDF]

Sci Rep, 2015
Mina M, Magi S, Jurman G, Itoh M, Kawaji H, Lassmann T, Arner E, Forrest ARR, Carninci P, Hayashizaki Y, Daub CO, FANTOM Consortium, Okada-Hatakeyama M, Furlanello C.   +13 more
europepmc   +1 more source

PanERBB CAR T-cells: Shifting gears toward a cure for fanconi anemia head/neck cancers. [PDF]

Mol Ther Oncol
Wiek C, Hüsken S, Scheckenbach K, Eikelberg I, Niktoreh N, Hanenberg H.   +5 more
europepmc   +1 more source

Increased EGFR/HER2 Pathway Activation Contributes to Skin Tumorigenesis in <i>Tpl2</i>^-^/- Mice. [PDF]

Cancers (Basel)
Purkey LR, Mehedincu S, Irvine C, Akdag R, Little M, Kothmann WW, Rus K, Greenberg E, Shady N, DeCicco-Skinner K.   +9 more
europepmc   +1 more source

HER2-Mutant Non-Small Cell Lung Cancer Podcast: Knowledge Is Power. [PDF]

Target Oncol
Subbiah V, Dietrich M, Le X.
europepmc   +1 more source

Human Mesenchymal Stromal Cells Derived from Different Tissues Show Similar Profiles of c-ErbB Receptor Family Expression at the mRNA and Protein Levels. [PDF]

Int J Mol Sci
Kosheverova V, Kharchenko M, Kamentseva R, Kotov M, Schwarz A, Kuneev I, Kotova A, Enukashvily N, Kornilova E.   +8 more
europepmc   +1 more source

Phosphoproteomic analysis reveals the diversity of signaling behind ErbB-inhibitor-induced phenotypes. [PDF]

FEBS J
Vaparanta K, Song Z, Farahani I, Jokilammi A, Merilahti J, Örling J, Virtanen N, Haapaniemi P, Sahlgren C, Elenius K, Paatero I.   +10 more
europepmc   +1 more source

A descriptive multilevel analysis associating COVID-19 with polymyositis: from genetic markers and candidate mediators to clinical hematological profiles. [PDF]

Front Med (Lausanne)
Chen M, Li H, Tong X, Zhang X.
europepmc   +1 more source

Single-cell profiling of ERBB family receptors identifies ERBB3 as a key regulator in head and neck squamous cell carcinoma progression. [PDF]

Discov Oncol
Luo Y, Li Y, Liu S, Hu R, Wu J.
europepmc   +1 more source

The ErbB-tyrosine kinase inhibitor, neratinib, has anti-inflammatory effects in multimorbidity by increasing macrophage efferocytosis via the upregulation of MerTK. [PDF]

J Inflamm (Lond)
Bowden KA, Wright C, Clark S, Correa TF, Johnston SA, Marriott HM, Francis SE, Prince LR.   +7 more
europepmc   +1 more source

Lipids regulate epidermal growth factor receptor activation by its ligands. [PDF]

Biochem Soc Trans
Hutchison JM, Lemmon MA.
europepmc   +1 more source